INM - InMed Pharmaceuticals Inc. Common Shares

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
2.2 0.0 (0.0%)	---	---	0.0 (0.0%)	-0.12 (-5.45%)	0.0 (0.0%)	0.0 (0.07%)	0.0 (0.07%)

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: Closed

Earnings & Ratios

Basic EPS:: -1.94
Diluted EPS:: -1.94
Basic P/E:: -1.134
Diluted P/E:: -1.134
RSI(14) 1m:: 0.0
VWAP:: 2.2
RVol:: 0.4659

Events

Period	Kind	Movement	Occurred At
1m	Price decrease 1m	2.16 -0.03 (-1.37%)	Oct 15 15:59
1m	Price increase 1m	2.21 +0.05 (+2.49%)	Oct 15 09:36
1m	Price decrease 1m	2.08 -0.09 (-4.15%)	Oct 15 08:55
10m	Price decrease 10m	2.08 -0.09 (-4.15%)	Oct 15 08:55